Brainstorm Cell Therapeutics Inc
General ticker "BCLI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $8.9M
Brainstorm Cell Therapeutics Inc does not follow the US Stock Market performance with the rate: -27.1%.
Estimated limits based on current volatility of 9.7%: low 1.99$, high 2.42$
Short-term BCLI quotes
Long-term BCLI plot
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $31.68MM | $24.54MM | $24.82MM |
| Operating Income | $-31.68MM | $-24.54MM | $-24.82MM |
| Non-Operating Income | $-0.13MM | $0.08MM | $0.55MM |
| R&D Expense | $22.33MM | $15.23MM | $13.96MM |
| Income(Loss) | $-31.81MM | $-24.46MM | $-24.28MM |
| Profit(Loss) | $-31.81MM | $-24.46MM | $-24.28MM |
| Stockholders Equity | $35.46MM | $19.34MM | $-3.02MM |
| Assets | $51.26MM | $29.28MM | $8.45MM |
| Operating Cash Flow | $-35.19MM | $-26.27MM | $-19.32MM |
| Capital expenditure | $0.38MM | $0.33MM | $0.03MM |
| Investing Cash Flow | $-4.45MM | $0.32MM | $1.00MM |
| Financing Cash Flow | $76.94MM | $6.97MM | $0.24MM |
| Earnings Per Share* | $-1.07 | $-0.67 | $-0.65 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.